(Q54381514)

29 May 2018

title

Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. (English)

1 reference

29 May 2018

1 reference

1

1 reference

29 May 2018

Chang Shan-chwen

5

1 reference

29 May 2018

Yee-Chun Chen

object named as

Yee-Chun Chen

4

0 references

Wan-Chin Chen

3

object named as

Wan-Chin Chen

1 reference

29 May 2018

Ching-Shiang Yang

2

object named as

Ching-Shiang Yang

1 reference

29 May 2018

publication date

1 August 2010

1 reference

29 May 2018

Journal of Microbiology Immunology and Infection

published in

1 reference

29 May 2018

volume

43

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

310-316

1 reference

29 May 2018

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

The spread of CTX-M-type extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Risk factors for coexistence of fluoroquinolone resistance and ESBL production among Enterobacteriaceae in a Greek university hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960048-5

7 January 2021

10.1016/S1684-1182(10)60048-5

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018